289 related articles for article (PubMed ID: 38355808)
1. Heterogeneity and tumoral origin of medulloblastoma in the single-cell era.
Sheng H; Li H; Zeng H; Zhang B; Lu Y; Liu X; Xu Z; Zhang J; Zhang L
Oncogene; 2024 Mar; 43(12):839-850. PubMed ID: 38355808
[TBL] [Abstract][Full Text] [Related]
2. Recent Advances in Pediatric Medulloblastoma.
Jackson K; Packer RJ
Curr Neurol Neurosci Rep; 2023 Dec; 23(12):841-848. PubMed ID: 37943476
[TBL] [Abstract][Full Text] [Related]
3. Treatment results of adults and children with medulloblastoma NCI, Cairo University experience.
Khalil EM
J Egypt Natl Canc Inst; 2008 Jun; 20(2):175-86. PubMed ID: 20029474
[TBL] [Abstract][Full Text] [Related]
4. SEOM clinical guideline for management of adult medulloblastoma (2020).
Luque R; Benavides M; Del Barco S; Egaña L; García-Gómez J; Martínez-García M; Pérez-Segura P; Pineda E; Sepúlveda JM; Vieito M
Clin Transl Oncol; 2021 May; 23(5):940-947. PubMed ID: 33792841
[TBL] [Abstract][Full Text] [Related]
5. DNA content and other prognostic features in childhood medulloblastoma. Proposal of a scoring system.
Schofield DE; Yunis EJ; Geyer JR; Albright AL; Berger MS; Taylor SR
Cancer; 1992 Mar; 69(5):1307-14. PubMed ID: 1739930
[TBL] [Abstract][Full Text] [Related]
6. Medulloblastoma: tumorigenesis, current clinical paradigm, and efforts to improve risk stratification.
Polkinghorn WR; Tarbell NJ
Nat Clin Pract Oncol; 2007 May; 4(5):295-304. PubMed ID: 17464337
[TBL] [Abstract][Full Text] [Related]
7. Pediatric medulloblastoma in the molecular era: what are the surgical implications?
Kameda-Smith MM
Cancer Metastasis Rev; 2020 Mar; 39(1):235-243. PubMed ID: 32095940
[TBL] [Abstract][Full Text] [Related]
8. Shedding light on adult medulloblastoma: current management and opportunities for advances.
Brandes AA; Franceschi E
Am Soc Clin Oncol Educ Book; 2014; ():e82-7. PubMed ID: 24857151
[TBL] [Abstract][Full Text] [Related]
9. Outcome and prognostic factors of desmoplastic medulloblastoma treated within a multidisciplinary treatment concept.
Rieken S; Gaiser T; Mohr A; Welzel T; Witt O; Kulozik AE; Wick W; Debus J; Combs SE
BMC Cancer; 2010 Aug; 10():450. PubMed ID: 20731859
[TBL] [Abstract][Full Text] [Related]
10. Macrophages in SHH subgroup medulloblastoma display dynamic heterogeneity that varies with treatment modality.
Dang MT; Gonzalez MV; Gaonkar KS; Rathi KS; Young P; Arif S; Zhai L; Alam Z; Devalaraja S; To TKJ; Folkert IW; Raman P; Rokita JL; Martinez D; Taroni JN; Shapiro JA; Greene CS; Savonen C; Mafra F; Hakonarson H; Curran T; Haldar M
Cell Rep; 2021 Mar; 34(13):108917. PubMed ID: 33789113
[TBL] [Abstract][Full Text] [Related]
11. Medulloblastoma: From Molecular Subgroups to Molecular Targeted Therapies.
Wang J; Garancher A; Ramaswamy V; Wechsler-Reya RJ
Annu Rev Neurosci; 2018 Jul; 41():207-232. PubMed ID: 29641939
[TBL] [Abstract][Full Text] [Related]
12. Very late relapse of medulloblastoma.
Cieślak E; Kepka L; Fijuth J; Marchel A; Kroh H
Folia Neuropathol; 2004; 42(1):49-53. PubMed ID: 15119746
[TBL] [Abstract][Full Text] [Related]
13. High-dose chemotherapy with autologous stem cell rescue followed by posterior fossa irradiation for local medulloblastoma recurrence or progression after conventional chemotherapy.
Ridola V; Grill J; Doz F; Gentet JC; Frappaz D; Raquin MA; Habrand JL; Sainte-Rose C; Valteau-Couanet D; Kalifa C
Cancer; 2007 Jul; 110(1):156-63. PubMed ID: 17541945
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological features of medulloblastoma: an overview with an emphasis on molecular biology.
de Haas TG; Kool M
Clin Neuropathol; 2007; 26(3):93-110. PubMed ID: 19157001
[TBL] [Abstract][Full Text] [Related]
15. Isolated Bone Recurrence of Medulloblastoma With MYCN Amplification and TP53 Loss: A Case Report.
Takahashi Y; Kudo K; Ogawa K; Sato T; Kamio T; Sasaki S; Kobayashi A; Ito T; Yamamoto T; Asano K; Ohkuma H; Kurose A; Ito E; Terui K
J Pediatr Hematol Oncol; 2022 Mar; 44(2):e593-e596. PubMed ID: 34133388
[TBL] [Abstract][Full Text] [Related]
16. New Approaches in Targeted Therapy for Medulloblastoma in Children.
Maier H; Dalianis T; Kostopoulou ON
Anticancer Res; 2021 Apr; 41(4):1715-1726. PubMed ID: 33813375
[TBL] [Abstract][Full Text] [Related]
17. Gorlin syndrome and desmoplastic medulloblastoma: Report of 3 cases with unfavorable clinical course and novel mutations.
Gururangan S; Robinson G; Ellison DW; Wu G; He X; Lu QR; McLendon R; Grant G; Driscoll T; Neuberg R
Pediatr Blood Cancer; 2015 Oct; 62(10):1855-8. PubMed ID: 25940061
[TBL] [Abstract][Full Text] [Related]
18. Brain tumors: Medulloblastoma, ATRT, ependymoma.
Baliga S; Gandola L; Timmermann B; Gail H; Padovani L; Janssens GO; Yock TI
Pediatr Blood Cancer; 2021 May; 68 Suppl 2():e28395. PubMed ID: 32386126
[TBL] [Abstract][Full Text] [Related]
19. Medulloblastoma: conventional radiation therapy in comparison to chemo radiation therapy in the post-operative treatment of high-risk patients.
Abd El-Aal HH; Mokhtar MM; Habib E; El-Kashef AT; Fahmy ES
J Egypt Natl Canc Inst; 2005 Dec; 17(4):301-7. PubMed ID: 17102823
[TBL] [Abstract][Full Text] [Related]
20. Mapping pediatric brain tumors to their origins in the developing cerebellum.
Okonechnikov K; Joshi P; Sepp M; Leiss K; Sarropoulos I; Murat F; Sill M; Beck P; Chan KC; Korshunov A; Sah F; Deng MY; Sturm D; DeSisto J; Donson AM; Foreman NK; Green AL; Robinson G; Orr BA; Gao Q; Darrow E; Hadley JL; Northcott PA; Gojo J; Kawauchi D; Hovestadt V; Filbin MG; von Deimling A; Zuckermann M; Pajtler KW; Kool M; Jones DTW; Jäger N; Kutscher LM; Kaessmann H; Pfister SM
Neuro Oncol; 2023 Oct; 25(10):1895-1909. PubMed ID: 37534924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
